BRIP1 and Familial prostate cancer: More recently, targeted sequencing of 94 cancer-predisposing genes in a patient cohort with early-onset/ familial prostate cancer led to the discovery of a germline mutation (c.847T>C) giving rise to FANCJ C283R that was classified as potentially pathogenic [23].